Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Giraldos"'
Autor:
Chantal Reina-Ortiz, Michael Constantinides, Alexis Fayd-Herbe-de-Maudave, Jessy Présumey, Javier Hernandez, Guillaume Cartron, David Giraldos, Rosana Díez, Isabel Izquierdo, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval, Alberto Anel, Martín Villalba
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
In this study we evaluated the potential of expanded NK cells (eNKs) from two sources combined with the mAbs daratumumab and pembrolizumab to target primary multiple myeloma (MM) cells ex vivo. In order to ascertain the best source of NK cells, we ex
Externí odkaz:
https://doaj.org/article/c66d7fd744d64dde8fe77da679284058
Autor:
Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval, Martín Villalba, Alberto Anel
Publikováno v:
Cells, Vol 11, Iss 3, p 392 (2022)
Natural killer (NK) cell-based therapies have emerged as promising anticancer treatments due to their potency as cytolytic effectors and synergy with concurrent treatments. Multiple myeloma (MM) is an aggressive B-cell malignancy that, despite develo
Externí odkaz:
https://doaj.org/article/8039a1f818234d8d920bd69c45d4c004
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
instname
Despite recent biomedical improvements in treating multiple myeloma, this disease still remains incurable. Toll-like receptors (TLRs) are key immune receptors that recognize conserved molecular patterns expressed by pathogens and damaged cells. Activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c8600d2a2397c37a48d6652c11dc38
http://zaguan.unizar.es/record/112076
http://zaguan.unizar.es/record/112076
Autor:
Chantal Reina-Ortiz, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval, Martín Villalba, Alberto Anel
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Cells
Cells, MDPI, 2022, 11 (3), pp.392. ⟨10.3390/cells11030392⟩
Cells, Vol 11, Iss 392, p 392 (2022)
instname
Cells
Cells, MDPI, 2022, 11 (3), pp.392. ⟨10.3390/cells11030392⟩
Cells, Vol 11, Iss 392, p 392 (2022)
International audience; Natural killer (NK) cell-based therapies have emerged as promising anticancer treatments due to their potency as cytolytic effectors and synergy with concurrent treatments. Multiple myeloma (MM) is an aggressive B-cell maligna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72621474bf6b90a6f3dc4a1ebe747d60
https://pubmed.ncbi.nlm.nih.gov/35159200
https://pubmed.ncbi.nlm.nih.gov/35159200
Autor:
Javier Hernandez, Isabel Marzo, Isabel Izquierdo, Luis Palomera, Javier Naval, Rosana Díez, Martin Villalba, Michael Constantinides, Jessy Présumey, Alberto Anel, Gemma Azaceta, Guillaume Cartron, Chantal Reina-Ortiz, Alexis Fayd-Herbe-de-Maudave, David Giraldos
Publikováno v:
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1853314. ⟨10.1080/2162402X.2020.1853314⟩
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Universidad de Zaragoza
OncoImmunology
OncoImmunology, Taylor & Francis, 2021, 10 (1), pp.1853314. ⟨10.1080/2162402X.2020.1853314⟩
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
International audience; In this study we evaluated the potential of expanded NK cells (eNKs) from two sources combined with the mAbs daratumumab and pembrolizumab to target primary multiple myeloma (MM) cells ex vivo. In order to ascertain the best s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82080b1e0362bb87c6b462675e35707
http://zaguan.unizar.es/record/99158
http://zaguan.unizar.es/record/99158
Autor:
Chantal Reina-Ortiz, Diego Sánchez-Martínez, Carlos Vilches, Daniel Woods, Isabel Marzo, Tania Calvo, Gemma Azaceta, Joaquín Marco-Brualla, Luis Palomera, María Gascón, Martin Villalba, Isabel Izquierdo, Alberto Anel, David Giraldos, Javier Naval, Judit Asenjo
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.19398. ⟨10.1038/s41598-020-76051-z⟩
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Consejo Superior de Investigaciones Científicas (CSIC)
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.19398. ⟨10.1038/s41598-020-76051-z⟩
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Consejo Superior de Investigaciones Científicas (CSIC)
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Adoptive transfer of allogeneic natural killer (NK) cells is becoming a credible immunotherapy for hematological malignancies. In the present work, using an optimized expansion/activation protocol of human NK cells, we generate expanded NK cells (eNK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6464e4fe425ae7025782fff7ec25b5ba
https://hal.umontpellier.fr/hal-03010044
https://hal.umontpellier.fr/hal-03010044